Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons

Brain Research

Volumn 1323, Issue , 2010, Pages 18-32

  Cady, Ryan J ^a   Durham, Paul L ^a  

^a MISSOURI STATE UNIVERSITY   (United States)

Author keywords

Cocoa; Headache; Inflammation; MAPK; MKP; Temporomandibular joint disorder; Trigeminal

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CACAO; CONTROLLED STUDY; DIET SUPPLEMENTATION; INJECTION; MIGRAINE; MOLECULE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TEMPOROMANDIBULAR JOINT DISORDER; TRIGEMINUS GANGLION; UPREGULATION;

ANIMALS; CACAO; CALCITONIN GENE-RELATED PEPTIDE; CELL COUNT; DIET; IMMUNOHISTOCHEMISTRY; INFLAMMATION; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORIC MONOESTER HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; TRIGEMINAL GANGLION;

ANIMALIA; RATTUS; THEOBROMA CACAO;

EID: 77953134116     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.01.081     Document Type: Article

References (58)

1. Abbey M.J., Patil V.V., Vause C.V., and Durham P.L. Repression of calcitonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J. Ethnopharmacol. 115 (2008) 238-248
2. Bhat N., Feinstein D., Shen Q., and Bhat A. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancerbinding protein-beta, and activating transcription factor-2. J. Biol. Chem. 277 (2002) 29584-29592
3. Buzzi M. Trigeminal pain pathway: peripheral and central activation as experimental models of migraine. Funct. Neurol. 16 (2001) 77-81
4. Carlsson, G., LeResche, L., 1995. Epidemiology of temporomandibular disorders. In: Sessle, B., Bryant, P., Dionne, R. (Eds.), Temporomandibular Disorders and Related Pain Conditions: Progress in Pain Research and Management, vol. 4. IASP Press, Seattle, pp. 211-226.
5. Caterina M., Schumacher M., Tominaga M., Rosen T., and Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
6. Chang L., and Karin M. Mammalian MAP kinase signaling cascades. Nature 410 (2001) 37-40
7. Cheng J.K., and Ji R.R. Intracellular signaling in primary sensory neurons and persistent pain. Neurochem. Res. 33 (2008) 1970-1978
8. Clark A. MAP kinase phosphatase 1: a novel mediator of biological effects of glucocorticoids. J. Endocrinol. 178 (2003) 5-12
9. Crown E.D., Ye Z., Johnson K.M., Xu G.Y., McAdoo D.J., and Hulsebosch C.E. Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp. Neurol. 199 (2006) 397-407
10. Dickinson R., and Keyse S. Diverse physiological functions for dual-specificity MAP kinase phosphatases. J. Cell Sci. 119 (2006) 4607-4615
11. Dillinger T.L., Barriga P., Escarcega S., Jimenez M., Salazar Lowe D., and Grivetti L.E. Food of the gods: cure for humanity? A cultural history of the medicinal and ritual use of chocolate. J. Nutr. 130 (2000) 2057S-2072S
12. Dodick D., and Silberstein S. Central sensitization theory of migraine: clinical implications. Headache 46 (2006) S182-S191
13. Durham P., and Russo A. Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. Mol. Endocrinol. 12 (1998) 1002-1009
14. Durham P., and Russo A. Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal. Mol. Endocrinol. 14 (2000) 1570-1582
15. Durham P., and Russo A. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J. Neurosci. 23 (2003) 807-815
16. Ferrari M.D. The economic burden of migraine to society. Pharmacoeconomics 13 (1998) 667-676
17. Garrett F.G., and Durham P.L. Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol. (2009) 1-12
18. Garry E., Delaney A., Blackburn-Munro G., Dickinson T., Moss A., Nakalenbe I., Robertson D., Rosie R., Robberecht P., Mitchell R., and Fleetwood-Walker S. Activation of p38 and p42/44 MAP kinase in neuropathic pain: involvement of VPAC and NK receptors and mediation by spinal glia. Mol. Cell. Neurosci. 30 (2005) 523-537
19. Grassi D., Lippi C., Necozione S., Desideri G., and Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr. 81 (2005) 611-614
20. Guzik T., Korbut R., and Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J. Physiol. Pharmacol. 54 (2003) 469-487
21. Hargreaves R. New migraine and pain research. Headache 47 (2007) S26-S43
22. Herb K., Cho S., and Stiles M. Temporomandibular joint pain and dysfunctioning. Curr. Pain Headache Rep. 10 (2006) 408-414
23. Holmlund A., Ekblom A., Hansson P., Lind J., Lundenberg T., and Theodorsson E. Concentration of neuropeptide substance P, Neurokinin A, calcitonin gene related peptide, neuropeptide Y and vasoactive intestinal polypeptide in the synovial fluid of the human temporomandibular joint. Int. J. Oral Maxillofac. Surg. 20 (1991) 228-231
24. Homma H., Takahashi T., Seki H., Ohtani M., Kondoh T., and Fukuda M. Immunohistochemical localization of inducible nitric oxide synthase in synovial tissue of human temporomandibular joints with internal derangement. Arch. Oral Biol. 46 (2001) 93-97
25. Isong U., Gangsky S., and Plesh O. Temporomandibular joint and muscle disorder-type pain in U.S. adults: the National Health Interview Survey. J. Orafac Pain 22 (2008) 317-322
26. Iversen H., and Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16 (1996) 412-418
27. Ji R. Mitogen-activated protein kinases as potential targets for pain killers. Curr. Opin. Investig. Drugs 5 (2004) 71-75
28. Ji R.R. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr. Drug Targets Inflamm. Allergy 3 (2004) 299-303
29. Keyse S. Protein phosphatases and the regulation of MAP kinase activity. Cell Dev. Biol. 9 (1998) 143-152
30. Kopp S. Neuroendocrine, immune, and local responses related to temporomandibular disorders. J. Orofac Pain 15 (2001) 9-28
31. Lewis T., Shapiro P., and Ahn N. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
32. Lipton J., Ship J.A., and Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J. Am. Dent. Assoc. 124 (1993) 115-121
33. Lipton R., Stewart W., Diamond S., Diamond M., and Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41 (2001) 646-657
34. Liu B., Gao H., Wang J., Jeohn G., Cooper C., and Hong J. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci. 962 (2002) 318-331
35. Matsui N., Ito R., Nishimura E., Yoshikawa M., Kato M., Kamei M., Shibata H., Matsumoto I., Abe K., and Hashizume S. Ingested cocoa can prevent high-fat diet-induced obesity by regulating the expression of genes for fatty acid metabolism. Nutrition 21 (2005) 594-601
36. Nagai H., Kumamoto H., Fukuda M., and Takahashi T. Inducible nitric oxide synthase and apoptosis-related factors in the synovial tissues of temporomandibular joints with internal derangement and osteoarthritis. J. Oral Maxillofac. Surg. 61 (2003) 801-807
37. Olesen J., and Jansen-Olesen I. Nitric oxide mechanisms in migraine. Pathol. Biol. (Paris) 48 (2000) 648-657
38. Pietrobon D., and Striessnig J. Neurobiology of migraine. Nat. Rev. Neurosci. 4 (2003) 386-398
39. Ramiro E., Franch A., Castellote C., Perez-Cano F., Permanyer J., Izquierdo-Pulido M., and Castell M. Flavonoids from Theobroma cacao down-regulate inflammatory mediators. J. Agric. Food Chem. 53 (2005) 8506-8511
40. Ramiro-Puig E., and Castell M. Cocoa: antioxidant and immunomodulator. Br. J. Nutr. 101 (2009) 931-940
41. Selmi C., Mao T., Keen C., Schmitz H., and Eric Gershwin M. The anti-inflammatory properties of cocoa flavanols. J Cardiovasc Pharmacol. 47 (2006) S163-S176
42. Sessle B. The neurobiology of facial and dental pain: present knowledge, future directions. J. Dent. Res. 66 (1987) 962-981
43. Shankland W. The trigeminal nerve. Part I: an over-view. Cranio 18 (2000) 238-248
44. Suenaga S., Abeyama K., Hamasaki A., Mimura T., and Noikura T. Temporomandibular disorders: relationship between joint pain and effusion and nitric oxide concentration in the joint fluid. Dentomaxillofac. Radiol. 30 (2001) 214-218
45. Suzuki I., Harada T., Asano M., Tsuboi Y., Kondo M., Gionhaku N., Kitagawa J., Kusama T., and Iwata K. Phosphorylation of ERK in trigeminal spinal nucleus neurons following passive jaw movement in rats with chronic temporomandibular joint inflammation. J. Orofac. Pain 21 (2007) 225-231
46. Takahashi T., Kondoh T., Ohtani M., Homma H., and Fukuda M. Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 88 (1999) 129-136
47. Takahashi T., Homma H., Nagai H., Seki H., Kondoh T., Yamazaki Y., and Fukuda M. Specific expression of inducible nitric oxide synthase in the synovium of the diseased temporomandibular joint. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 95 (2003) 174-181
48. Thalakoti S., Patil V., Damodaram S., Vause C., Langford L., Freeman S., and Durham P. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache 47 (2007) 1008-1023
49. Thut P., Hermanstyne T., Flake N., and Gold M. An operant conditioning model to assess changes in feeding behavior associated with temporomandibular joint inflammation in the rat. J. Orofac. Pain 21 (2007) 7-18
50. Turjanski A., Vaque J., and Gutkind J. MAP kinases and the control of nuclear events. Oncogene 26 (2007) 3240-3253
51. Wang X., and Liu Y. Regulation of innate immune response by MAP kinase phosphatase-1. Cell. Signal. 19 (2007) 1372-1382
52. Wei H., Zhao W., Wang Y., and Pertovaara A. Pain-realated behavior following REM sleep deprivation in the rat: influence of peripheral nerve injury, spinal glutamatergic receptors and nitric oxide. Brain Res. 1148 (2007) 105-112
53. Williamson D., and Hargreaves R. Neurogenic inflammation in the context of mirgraine. Microsc. Res. Tech. 53 (2001) 167-178
54. Wu J., Roth R., Anderson E., Hong E., Lee M., Choi C., Neufer P., Shulman G., Kim J., and Bennett A. Mice lacking MAP kinase phophatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. Cell Metab. 4 (2006) 61-73
55. Yang C.M., Hsieh H.L., and Lee C.W. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med. J. 28 (2005) 813-823
56. Yun H.-Y., Dawson V., and Dawson T. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10 (1996) 291-316
57. Zhang W.Y., Liu H.Q., Xie K.Q., Yin L.L., Li Y., Kwik-Uribe C.L., and Zhu X.Z. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] suppresses the expression of cyclooxygenase-2 in endotoxin-treated monocytic cells. Biochem. Biophys. Res. Commun. 345 (2006) 508-515
58. Zhao Q., Wang X., Nelin L.D., Yao Y., Matta R., Manson M.E., Baliga R.S., Meng X., Smith C.V., Bauer J.A., Chang C.H., and Liu Y. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203 (2006) 131-140